Speci®c nuclear factor-DNA complexes formed within the promoters and enhancers are essential for transcriptional regulation. For eukaryotic systems, however, some DNA motif(s) are capable of binding to a family of related factors, thus making it dicult to identify the factor actually binding on the chromatic DNA in vivo and modulating the local transcription processes. To resolve this matter, we have re®ned a chromatin immunoprecipitation assay. Using the assay, we could directly link the regulatory functions of two members of the AP1/NF-E2 transcription factor family and their stable binding in vivo within distinct chromatin regions. The study demonstrated the feasibility of a general scheme in the determination of the identity of speci®c factor(s), among a group of family members, bound at unique sequence(s) in living mammalian cells.
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The transcription of many eukaryotic genes is regulated through speci®c protein-DNA complexes formed at distinct sequence motifs. However, degeneracy of factor-binding exists. That is, dierent members of a family of nuclear factors could recognize and bind to the same sequence motif (reviewed in Boulikas, 1994) . One class of such motifs with degeneracy of factor-binding is AP1/NF-E2, which has the consensus core sequence of 5'-TGA(G/ C)TCA-3'/3'-ACT(C/G)AGT-5'. This motif has been implicated in the regulation of a number of genes. Factors recognizing the AP1/NF-E2 motif in vivo include the well-known AP1 (homodimers of the oncogene product c-Jun, or heterodimers of c-Fos and c-Jun) (Lee et al., 1987; Angel et al., 1988b) , a hematopoietic transcription factor NF-E2 (Andrews et al., 1993) , the homodimers of the small maf polypeptide family, and heterodimers of the small maf with several other ubiquitous polypeptides (Blank and Andrews, 1997; Motohashi et al., 1997 and references therein) .
The protooncogene c-jun is one of the most extensively studied members of the`early response' genes. It encodes the major component c-Jun of the transcription factor AP1. Transcription of c-jun is rapidly enhanced in response to various stimuli including UV, growth factors, cytokines, tumor promoters, and carcinogens, etc. (Reviewed in Angel and Karin, 1991) . Based on the presence of two AP1 motif-like sequences in the c-jun promoter, and that c-jun promoter can be activated by overexpression of c-jun , it was proposed that c-Jun acts on its own promoter by a positive feed-back mechanism (Angel et al., 1988a; Devary et al., 1991;  Figure 1 ). Although the sequences of the two AP1-like motifs in the c-jun promoter (Table 1) do not have the typical central core of AP1/NF-E2 binding sites, i.e. 5'-TGA (C/G) TCA-3', they do bind AP1 in vitro (Angel et al., 1988a; Angel and Karin, 1991) . Also in vivo footprinting analysis indicated that both AP1 motifs in living human cells are occupied by factors before and after UV induction (Rozek and Pfeifer, 1993; Herr et al., 1994) .
On the other hand, site-direct mutagenesis in conjunction with DNA transfection, and transgenic mice studies have demonstrated the essential role of the AP1/NF-E2 motif in the positive as well as negative functioning of several erythroid-speci®c transcriptional regulatory elements (Mignotte et al., 1989; Moi and Kan, 1990; Ney et al., 1990; Talbot and Grosveld, 1991; Huang et al., 1998, and references therein) . At the same time, genomic footprinting analysis indicated that the AP1/NF-E2 motifs within several mammalian erythroid-speci®c regulatory elements including the locus-control-region of the human b globin locus or so-called b-globin-LCR (Figure 1 ), are occupied in vivo by factors in an erythroid lineage and developmental stage speci®c manner (Reddy and Shen, 1991; Ikuta and Kan, 1991; Zhang et al., 1993) . However, due to the multiplicity of factor-recognition of the AP1/NF-E2 motif as mentioned above, it has been dicult to ascertain whether NF-E2, or another factor such as AP1, actually binds at these transcription regulatory elements on native chromatin in vivo. This last point is especially problematic for erythroid cells of embryonic/ fetal origin (see discussions later).
We have used the c-jun promoter and the b-globin-LCR (Figure 1 ) as the test systems for the re®nement of a general approach to determine the identity of nuclear factor(s) bound at speci®c chromatin regions in vivo. As shown below, the combination of formaldehyde crosslinking of chromatin (Solomon and Varshavsky, 1985) , chromatin precipitation with speci®c antisera (Gould et al., 1990) , and detection of speci®c genomic sequence by PCR (Alberts et al., 1998; Rundlett et al., 1998) appears to be a feasible and reproducible assay for the above purpose.
HS-2 enhancer of human b-globin-LCR is bound with NF-E2 in K562
The strategy outlined in Figure 2a was ®rst used to see whether NF-E2 binds in vivo to the HS-2 enhancer b-globin-LCR in the human fetal/erythroid cell line K562, in which the embryonic and fetal globin genes are actively transcribing (Lozzio and Lozzio, 1975) . Also, both AP1 and NF-E2 are abundantly expressed in K562 cells (Ney et al., 1990; Talbot and Grosveld, 1991) . This enhancer consists of two tandemly arranged AP1/NF-E2 motifs with the coding-strand sequence 5'-GCTGAGTCA-3' and 5'-GATGAGTCA-3', respectively. Both motifs are capable of binding in vitro with AP1 as well as with NF-E2 (Ney et al., 1990; Talbot and Grosveld, 1991) .
The experiments were carried out as described in the legend of Figure 2A . As shown in the top panel of Figure 2B , the intensities of the PCR signals derived from the human actin pseudogene sequence (+385 to +1228) are similar in the immunoprecipitates generated with anti-NF-E2 (lane 6) and with the preimmune serum (lane 7). However, K562 chromatin immunoprecipitated with the anti-NF-E2 serum is enriched with the HS-2 element of bglobin-LCR by approximately 20-fold. This is estimated by using PCR signals of a serial dilutions of the preimmune supernatant from the immunoprecipitation (lanes 1 ± 5) as the standards. This enrichment of HS-2 is not observed in the preimmune precipitate of K562 chromatin (lane 7). On the contrary, sequence from +239 to +502 of the epidermal-speci®c keratin gene is not all enriched (second panel, Figure 2B ). Use of primers derived from a human e-and Gg-globin intergenic sequence (76908 to 76515 upstream of Gg) also detects no 
Transcription factor-chromatin interaction P Daftari et al enrichment of this region in the anti-NF-E2 chromatin immunoprecipitate (bottom panel, Figure  2B ). There is no previous evidence, either biochemical or from sequence homology search, for NF-E2 binding to DNA 1 kb upstream or downstream of the actin, keratin and globin intergenic sequence described above. Although our experimental conditions did allow some non-speci®c chromatin immunoprecipitation by the preimmune serum (lanes 7 of Figure 2B and lanes 5 of Figure 3) , the enrichment of speci®c chromatin regions by anti-NF-E2 antibody is much higher when compared to the preimmune precipitates. As expected, the HS-2 sequence is not enriched in anti-NF-E2 precipitated chromatin from non-erythroid HeLa cells (data not shown).
c-jun promoter is bound with AP1, but not NF-E2, in K562 cells
We then tested whether the AP1-like motifs in the c-jun promoter are bound with AP1 and/or NF-E2 in K562 cells (Figure 3) . In comparison to the pre-immune supernatant samples (lanes 1 ± 3 of top panel, Figure 3 ) or the actin sequence (second panel from top, Figure  3) , the c-jun promoter is speci®cally enriched by more than tenfold in the anti-c-Jun immunoprecipitate (lane 4 of top panel, Figure 3 ). This enrichment is not observed in the preimmune precipitate of K562 chromatin (lane 5 of top panel, Figure 3 ). Nor is it in the anti-NF-E2 immunoprecipitate (lane 6 of top panel, Figure 3 ). These data strongly support that AP1 exerts its regulatory function on the c-Jun promoter through stable chromatin-binding at the two AP1-like motifs in the promoter (Angel et al., 1988a; Devary et al., 1991; Rozek and Pfeifer, 1993; Herr et al., 1994) .
All four DNase I-hypersensitive sites of human b-globin-LCR are bound with NF-E2, but not AP1, in K562 cells Besides HS-2, there are three other major DNase Ihypersensitive sites in the human b-globin-LCR: HS-1, HS-3, and HS-4. Each of these sites contains at least one AP1/NF-E2 motif (Figure 1 ). Similar to HS-2, these AP1/NF-E2 motifs could also bind AP1 or NF-E2 in vitro (Lowrey et al., 1992; Fleenor and Kaufman, 1993) . Genomic footprinting has been applied to HS-3 and, as HS-2, its AP1/NF-E2 motif is bound with Figure 2 (A) General strategy of immunoprecipitation of chromatin bound with the erythroid-speci®c transcription factor NF-E2. K562 cells were harvested at approximate density of 0.5610 5 cells per ml. The procedures and conditions for formaldehyde ®xation in vivo, sonication, and immunoprecipitation of chromatin follow the study by Orlando and Paro (1993) . Anti-NF-E2 serum of Western blot and immunoprecipitation quality (data not shown) is from rabbit challenged with GST-p45 fusion polypeptide. Protein G-Sepharose 4 fast¯ow beads were used to bind the immunocomplexes. The chromatin samples were precleared twice with the preimmune serum. The immunoprecipitation reactions were then carried out with the anti-NF-E2, the preimmune serum, or the Protein-G sepharose beads only. The last is referred to as the`total precipitate' in (B). PCR primers used for analysis of speci®c regulatory regions are shown in Figure 1 and the primer sequences are available upon request. After puri®cation and reversing of the crosslinks, the precipitated DNA was used as the template for PCR reaction. PCR samples of serial dilutions of the supernatant DNA were used as standards. (B) PCR analysis of HS-2 region in chromatin immunoprecipitated with anti-NF-E2. PCR were carried out as described (A), with dierent DNA samples as the templates, and analysed by ethidium bromide-agarose gel electrophoresis. Lanes 1 ± 5, serial dilutions of preimmune supernatant DNA from immunoprecipitation. The numbers above the lanes indicate the fold of dilutions. Lane 6, anti-NF-E2 precipitate. Lane 7, preimmune precipitate. Lane 8, sepharose bead only without any antiserum Figure 3 PCR analysis of c-jun promoter and human b-globin-LCR regions in chromatin immunoprecipitates. PCR reactions and gel electrophoresis were carried out as described in Figure 2 . Lanes 1 ± 3, serial dilutions of preimmune supernatant DNA from the immunoprecipitation. Lanes 4, anti-c-jun precipitate. Lanes 5, preimmune precipitate. Lanes 6, anti-NF-E2 precipitate factors in K562 cells . Our PCR analysis of immunoprecipitated chromatin samples suggest that HS-1, HS-3, and HS-4, similar to HS-2, are all stably bound with the NF-E2 factor in vivo. Yet, no binding of AP1 could be detected (compare lane 6 to lanes 4 and 5 for each of the lower four panels, Figure 3) .
The data of Figure 3 provide substantial evidence for the invovlement of NF-E2 in the regulatory function of b-globin-LCR in human embryonic/fetal erythroid cells. This involvement could be at the level of interaction with dierent activators/co-activators (Amrolia et al., 1997; Cheng et al., 1997; Gavva et al., 1997) , or at the step of chromatin remodeling (Armstrong and Emerson, 1996; Gong et al., 1996) . Previously, the best evidence for a functional role of NF-E2 in mammalian globin gene regulation is the concomitant loss of expression of the p45 gene and the globin gene family in CB3, a variant cell line of the mouse adult erythroid MEL cells (Lu et al., 1994; Kotkow and Orkin, 1995) . No such data, however, is available for embryonic/fetal erythroid cells. Attempts to establish the role of NF-E2 in embryonic/fetal globin gene regulation by knock-out mice technology have also failed as p45/NF-E2 null mice did not show any severe defect of globin expression (Shivdasani and Orkin, 1995; Martin et al., 1998) . The latter results are most likely due to the functional degeneracy and compensatory mechanisms among NF-E2 and other factors capable of binding to the AP1/NF-E2 motifs within the globin LCRs.
Dierent combinations of the steps outlined in Figure 2A have been used previously in other studies, many of which were on relatively abundant DNAbound proteins such as the histones (Solomon et al., 1988, Orlando and Paro, 1993; Alberts et al., 1998; Rundlett et al., 1998) . Furthermore, Drosphila or yeast cells were analysed in most cases (Orlando and Paro, 1993; Walter and Biggin, 1996; Rundlett et al., 1998) , which have much smaller genome complexities than the mammals. More recently, the above approach has been used for the study of Oct-4 factor binding in the Osteopontin enhancer (Botquin et al., 1998) , and for the demonstration of association of transcriptional activators with virus-induced promoters in vivo (Wathelet et al., 1998) . The reciprocal binding patterns of the AP1 and NF-E2 factors in the c-jun promoter and the b-globin-LCR in K562 cells (Figures 2 and 3) have clearly demonstrated the feasibility of the strategy outlined in Figure 2A for determining the identity of nuclear factor(s) bound in vivo at speci®c motif(s) to which a family of related DNA-binding factors could recognize and interact with.
